Pular para o conteúdo

Parecer de revisão por pares

30 jan 2026

Reviewed article: Moura CC, Toledo LV, Nogueira DA, Boscarol GT, Chaves RL, Marinho CAC, Rodrigues YM, Santana MCV, Alves BO, Lourenço BG, Chaves ECL, Chianca TCM. Factors associated with symptoms of depression, anxiety, and stress post-COVID-19, in university students: a cross-sectional study, Minas Gerais, 2023-2024. Epidemiol Serv Saude. 2026:35;e20250241

28 jan 2026

Reviewed article: Nogueira HR, Amorim EL, Genaro GD, Lourenço MCS, Dantas VHS, Sousa LVA. Disparities in time-to-treatment initiation and therapeutic modalities for malignant melanoma of the skin: a cross-sectional study, Brazil, 2013-2023. Epidemiol Serv Saude. 2026:35;e20250025

13 jan 2026

Reviewed article: Santos LB, Figueredo LJA, Elizeu RHB, Carvalho WS, Padua CM, Miranda SS. Clinical, epidemiological, and laboratory profile of people with tuberculosis in a referral center: a cohort study, Belo Horizonte, 2013-2021. Epidemiol Serv Saude. 2026:35;e20240787

17 dez 2025

Reviewed article: Galvão RLF, Pinheiro MCC, Silva AM, Sá SLCS, Barbosa L, Sampaio TL, Bezerra FSM. Prevalence of schistosomiasis and associated risk factors in endemic communities: cross-sectional study, Patioba and Colônia Miranda, Sergipe, 2022-2023. Epidemiol Serv Saude. 2026:35;e20250399

4 dez 2025

Reviewed article: Bastos MES, Nascimento AJF, Soares MTF, Spinelli MBAS, Low ST. Knowledge, attitudes and practices of pregnant women for preventing risks and accidents with their newborns: cross-sectional study, Recife, 2024. Epidemiol Serv Saude. 2026:35;e20240822

3 dez 2025

Reviewed article: Fernandes RRA, Andrade KRC, Zimmermann IR. Nivolumab and pembrolizumab in the treatment of metastatic melanoma: a retrospective budget impact analysis from the perspective of the Brazilian National Health System, Brazil, 2019-2022. Epidemiol Serv Saude. 2026:35;e20240679.

3 dez 2025

Reviewed article: Fernandes RRA, Andrade KRC, Zimmermann IR. Nivolumab and pembrolizumab in the treatment of metastatic melanoma: a retrospective budget impact analysis from the perspective of the Brazilian National Health System, Brazil, 2019-2022. Epidemiol Serv Saude. 2026:35;e20240679

3 dez 2025

Reviewed article: Fernandes RRA, Andrade KRC, Zimmermann IR. Nivolumab and pembrolizumab in the treatment of metastatic melanoma: a retrospective budget impact analysis from the perspective of the Brazilian National Health System, Brazil, 2019-2022. Epidemiol Serv Saude. 2026:35;e20240679

18 nov 2025

Reviewed article: Santos ACJ, Quintino ND, Silva JEFA, Nunes MCP, Pereira JA, Sabino EC, Mota AF, Haikal DS. Hospitalizations due to stroke and their relationship with Chagasdisease: a population-based analytical study using data from the Hospital Information System of the Brazilian National Health System, Minas Gerais, Brazil, 2022. Epidemiol Serv Saude. 2026:35;e20240901

7 nov 2025

Reviewed article: Baggio AC, Mahana G, Oliveira C, Campos JC, Trevisol DJ, Schuelter-Trevisol F, Traebert E, Traebert J. Self-perception of depressive symptoms, self-reported medical diagnosis, and associated factors: findings from the Brazilian Longitudinal Study of Aging, 2019-2021. Epidemiol Serv Saude. 2026:35;e20250158

24 out 2025

Reviewed article: Mori MM, Piran CMG, Cargnin AVE, Moroskoski M, Fernandes CAM, Moura DRO, Furtado MD.Geographical distribution and spatial autocorrelation of newborns with orofacial clefts: an epidemiological study, Paraná, 2018-2022. Epidemiol Serv Saude. 2025:34;e20250189

24 out 2025

Reviewed article: Cordeiro DC, Aguiar EB, Luiz RR, Sacramento DS, Paolino PLW, Gonçalves MJF, Trajman A. Effect of successive tuberculin skin test readings on healthcare professionals’ proficiency: an operational observational study in five high-tuberculosis-burden Brazilian municipalities, 2023-2024. Epidemiol Serv Saude. 2025:34;e20240795

24 out 2025

Reviewed article: Cordeiro DC, Aguiar EB, Luiz RR, Sacramento DS, Paolino PLW, Gonçalves MJF, Trajman A. Effect of successive tuberculin skin test readings on healthcare professionals’ proficiency: an operational observational study in five high-tuberculosis-burden Brazilian municipalities, 2023-2024. Epidemiol Serv Saude. 2025:34;e20240795